Rekombinanter Amyloid beta (4-10) (AA 1-42) Antikörper
-
- Target
- Amyloid beta (4-10)
- Antikörpertyp
- Recombinant Antibody
- Bindungsspezifität
- AA 1-42
- Reaktivität
- Human
- Wirt
- Maus
- Klonalität
- Monoklonal
- Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- Verwendungszweck
- Anti-Amyloid beta (aa 4-10) [WO2], Mouse IgG2a, kappa
- Spezifität
- Recognises amino acid residues 4-10 of human Amyloid β.
- Produktmerkmale
-
Original Species of Ab: Mouse
Original Format of Ab: IgG2a
- Aufreinigung
- Protein A affinity purified
- Immunogen
- Synthetic peptides, corresponding to amino acids 1-42 of human beta amyloid, conjugated to KLH.
- Klon
- WO2
- Isotyp
- IgG2a kappa
-
- Applikationshinweise
- This antibody binds to amyloid beta peptides and may be used in Western Blotting as well as ELISA and IHC. Youn et al. (PMID: 31077246) describes the use of an HRP-conjugate of the IgG2a version of WO2 in a diagnostic Multimer Detection System-Oligomeric Amyloid-β assay to measure oligomerization tendencies in the blood.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease." in: Frontiers in cellular neuroscience, Vol. 11, pp. 291, (2017) (PubMed).
: "
-
A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease." in: Frontiers in cellular neuroscience, Vol. 11, pp. 291, (2017) (PubMed).
-
- Target
- Amyloid beta (4-10)
- Hintergrund
- Abeta
- UniProt
- P05067
-